Tianjin Establishes Yujiapu Medical Big Data Industry Base, Showcasing Multiple Application Achievements and Preparing for IPO

On April 26, the “Medical Big Data Application and Development Conference,” themed “Sharing, Interconnectivity, and Building a Community of Medical and Health Big Data,” was held in the Binhai New Area of Tianjin. Focusing on the development and application of medical big data, the conference introduced special policies, established industry standards, promoted information security and technological applications, fostered a collaborative industrial ecosystem, released achievements in technological applications, and explored new models of hospital management in the big data era, thereby fully exploring the development potential of medical big data exploitation and application.

The conference is hosted by the Wu Jieping Medical Foundation, Tianjin Municipal Health and Family Planning Commission, and the People’s Government of Binhai New Area, Tianjin Municipality; co-organized by the Administrative Committee of the Central Business District of Binhai New Area, Tianjin, LinkDoc Technology Co., Ltd., and Yujiapu Medical Big Data Industry Base. It is part of the series of events commemorating the 100th anniversary of Wu Jieping’s birth.

The opening ceremony was attended by Academician Fan Daiming, Vice President of the Chinese Academy of Engineering; Xiao Meng, Chairman of the Wu Jieping Medical Foundation; Academician Wang Chen, President of China-Japan Friendship Hospital; Cao Zeyi, former Vice Minister of the Ministry of Health; Professor Wu Yilong, Chairman of the Chinese Society of Clinical Oncology; Xu Siwei, Chairman of Sinosteel Corporation; Professor Zhang Xun, President of the Thoracic Surgeons Branch of the Chinese Medical Doctor Association; Professor Dong Jiahong, Dean of the School of Medicine at Tsinghua University; Professor Xu Ruihua, President of Sun Yat-sen University Cancer Center; Zhang Yuzhuo, Member of the Standing Committee of the Tianjin Municipal Party Committee and Secretary of the Binhai New Area Party Committee; Cao Xiaohong, Vice Mayor of Tianjin Municipality; Wang Xudong, Deputy Director of the Tianjin Municipal Health and Family Planning Commission; Zheng Weiming, Party Group Secretary and Director of the Administrative Committee of the Central Business District in Binhai New Area, Tianjin; Li Cailiang, Member of the Standing Committee of the Binhai New Area Party Committee and Secretary-General of the Party Committee; and Guo Jingping, Deputy District Mayor of Binhai New Area, Tianjin.

Leaders from the National Health and Family Planning Commission, renowned disciplinary leaders from the Chinese Academy of Sciences, Tsinghua University, and the Chinese Academy of Medical Sciences, officials in charge of information and medical big data from local health commissions, hospital presidents, as well as authoritative experts and scholars from domestic and international fields such as medicine, computational technology, information technology, artificial intelligence, statistics, health economics, evidence-based science, and social security and medical insurance, gathered in the Binhai New Area. They convened to discuss the development and application of China’s medical big data, seek effective implementation pathways, promote the concept of interconnected applications, stimulate sharing and collaboration between the healthcare system and the industrial ecosystem, and advance the development of the medical big data discipline in China. The conference was attended by nearly 1,000 representatives, including health administrative departments from major provinces and cities across China, presidents and disciplinary leaders from over 300 Grade A tertiary hospitals, leading enterprises in the medical industry, high-tech companies, internet healthcare providers, insurance institutions, and hospital information system vendors.

“Healthy China” is the long-term strategic goal for the development of China’s healthcare sector, representing a grand vision toward which all stakeholders in the medical industry strive. At the current stage, the development and application of big data in healthcare have become a primary driving force accelerating the advancement of the healthcare sector, serving as the foundation for precision medicine and a prerequisite for intelligent medicine.

It is understood that in the field of medical big data, China has reached a world-leading level in data collection, classification, and basic analysis. However, the key to realizing the practical promotional role of medical big data in healthcare and its related upstream and downstream sectors, and to providing substantive support for the healthcare industry, lies in “application.” Experts note that if the application of medical big data becomes industrialized, it will drive several trillion-yuan markets in the future, including disease prevention, pharmaceutical production, and health insurance.

Hubble Medical Big Data-Assisted Decision-Making System Unveiled at the Conference

At this conference, several big data technology application achievements were unveiled, including the Standardized Diagnostic and Treatment Terminology for Thoracic Surgical Diseases, the “Zhongke Tianqi” Hospital Risk Monitoring and Management System, and the Hubble Medical Big Data-Assisted Decision-Making System. All of these represent the highest national standards in their respective specialized fields. Taking research on “the impact of skip metastasis to lymph nodes in lung cancer patients” as an example, medical big data has played a significant role in innovative applications within translational medicine and personalized treatment. Incorporating medical big data into treatment decision-making can extend patients’ survival by at least one year.

At the same time, the Oncology Department of the Wu Jieping Medical Foundation was established at the conference, and the global "Tianchi" Medical Big Data Innovation Competition and the Intelligent Diagnosis Competition for Pulmonary Nodules were launched concurrently.

As a critical foundational strategic resource for the nation, health and medical big data has received significant attention from the Central Committee of the Communist Party of China and the State Council regarding its application and development. Over the past two years, numerous policy documents have been issued to provide guidance on health care and health and medical big data, driving their development at the national level. Across China, relevant research is being actively promoted, and related industries are undergoing robust development. Within the broader framework of coordinated development in the Beijing-Tianjin-Hebei region, Tianjin Binhai New Area has been continuously exploring effective means and pathways for leveraging big data to serve economic and social development. By innovating policies and optimizing the business environment, the area is providing a strong platform for the growth of the big data industry.

Lingke Technology CEO Zhang Tianze Participates in the Plaque-Awarding Ceremony for the Big Data Industrial Base

At the conference, the “Yujiapu Medical Big Data Industrial Base” was officially unveiled. The Central Business District of Binhai New Area will fully support the development of the Yujiapu Medical Big Data Industrial Base through “major” initiatives such as issuing special industrial policies, collaborating with leading enterprises for joint development, and establishing a “think tank” composed of top-tier experts. It aims to actively explore new models of “Internet + Healthcare” services, build a healthcare industry chain covering the entire life cycle, and strive to establish it within three to five years as a medical big data industrial base and demonstration zone for development and application with international influence and national exemplary role. This effort seeks to promote the development of the regional healthcare big data industry and utilize market mechanisms to optimize the provision of healthcare services, creating a “Tianjin Model.”

Five industry-leading enterprises, including the Intellectual Property Operation and Management Center of the Chinese Academy of Sciences, Sinosteel Kedeh Incubator, Qilu Pharmaceutical Group, LinkDoc Technology, and Beijing Meili Sansheng Technology Co., Ltd. (Shengminghui), have entered into cooperation agreements with the base to jointly develop the facility. These partners will leverage their respective resources to foster the agglomeration of enterprises engaged in the collection, analysis, R&D, and application of medical big data within the base. They will also support and facilitate the establishment and introduction of public service platforms related to the medical big data industry, thereby building and refining the base’s industrial ecosystem.

Meanwhile, the Base has appointed ten leading domestic experts as senior industry advisors, including Xiao Meng, Chairman of the Wu Jieping Medical Foundation; Wu Yilong, Member of the U.S. National Academy of Sciences and Chairman of the Chinese Society of Clinical Oncology (CSCO); Cao Zeyi, renowned expert in obstetrics and gynecology; Sui Xueqing, Director of the Intellectual Property Operation and Management Center of the Chinese Academy of Sciences; Han Yishun, Executive Dean of the Institute for Data Science at Tsinghua University; Zhang Xun, President of the Thoracic Surgery Branch of the Chinese Medical Doctor Association; Xu Ruihua, President of Sun Yat-sen University Cancer Center; Dong Jiahong, President of Beijing Tsinghua Changgung Hospital; and Cai Jiangnan, Director of the Healthcare Management and Policy Research Center at CEIBS. These experts provide consultation and recommendations on the formulation of the Base’s industrial development strategies, plans, and key policies, as well as professional guidance on the implementation and construction of new technologies, new business models, and demonstration projects.

The initial operational space of the Yujiapu Medical Big Data Industrial Base is located in the New Finance Building within the Yujiapu Financial District. It is developed, constructed, and operated on a daily basis by Sinosteel Kede Incubator, an innovation and entrepreneurship incubator under Sinosteel Corporation, a large central state-owned enterprise. The base will provide a favorable development environment for companies specializing in medical big data and is poised to become a primary hub for entrepreneurial activities and the convergence of innovative elements such as talent, technology, and data resources in the medical big data industry.

While establishing the Yujiapu Medical Big Data Industrial Base, the Central Business District (CBD) also integrated and layered the innovation policies of the Free Trade Zone (FTZ), the National Independent Innovation Demonstration Zone, and the Mass Entrepreneurship and Innovation Demonstration Base, taking into account regional industrial characteristics and practical development needs. To this end, it formulated the “Yujiapu Health and Medical Big Data Industry Development Policy.” At the conference, Zheng Weiming, Party Secretary of the Administrative Committee of the Tianjin Binhai New Area Central Business District, Deputy Director of the Tianjin Free Trade Zone Administrative Committee, and Director of the Central Business District Administrative Committee, officially released this policy package.

The special policies include the following eight provisions, which provide a favorable environment for the regional development of the medical big data industry and attract leading enterprises and high-quality talent to rapidly cluster:

Establish industrial funds, utilizing equity investments or direct investments, to support the development of high-growth enterprises in the health and medical big data sector;

Healthcare big data enterprises can enjoy priority access to the “enhanced” policy support under various initiatives in the Central Business District (CBD) designed to foster business development;

Support enterprises in leveraging mobile health solutions to deliver smart elderly care and cloud-based health management services within central business district communities and elderly care institutions;

Enterprises introducing talent can enjoy immediate household registration upon employment, and receive priority recommendation for preferential policies such as the Binhai New Area Talent Support Program.

Support leading enterprises in the industry to establish specialized mass innovation spaces and other incubation carriers around the development and utilization of health and medical big data resources, and enjoy various policies supporting the development of mass innovation spaces in demonstration bases for mass entrepreneurship and innovation;

Encourage R&D innovation by establishing collaborative innovation platforms for industry, academia, and research, as well as academician and postdoctoral workstations; provide financial matching support at varying ratios to enterprises within the district that secure special-purpose funds.

Reduce operating costs by providing subsidies to encourage enterprises to purchase R&D, production, and testing equipment for health and medical big data through financial leasing, as well as to procure big data and cloud computing services.

Build a robust industrial ecosystem by hosting various innovation forums and startup competitions, and by intensifying promotional efforts.

Leveraging this conference, the Beijing-Tianjin-Hebei Health and Medical Big Data Industry Promotion Association, jointly initiated by the Wu Jieping Foundation and LinkDoc Technology, was officially unveiled and established. The association’s inaugural membership comprises over 50 entities, bringing together industry leaders such as Alibaba, Baidu, Tencent, and LinkDoc Technology; research institutions including the Intellectual Property Center of the Chinese Academy of Sciences and Tsinghua University; investment and financing firms represented by Broadband Capital; and innovative incubators exemplified by Sinosteel Kede Incubator. As the first industry organization dedicated to the health big data sector in the Beijing-Tianjin-Hebei region, the association will actively break down regional data barriers, promote the sharing of industrial resources, leverage the driving role of leading enterprises, and jointly foster a robust industrial ecosystem.